Coopersurgical has agreed to buy Teva Pharmaceuticals Industries Ltd.'s Paragard intrauterine device (IUD) for $1.1 billion in cash and is expected to close the deal late this year. The acquisition includes Teva's exclusive Paragard manufacturing facility in Buffalo, N.Y., and marks continued effort to divest Teva's global women's health business, according to the company. Read More
